You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| HealthCor Management | 0 | 5,500,000 | 0 | 5,500,000 | 5,500,000 | 5.1% |
| HealthCor Associates | 0 | 5,500,000 | 0 | 5,500,000 | 5,500,000 | 5.1% |
| HealthCor Offshore Master Fund | 0 | 1,606,731 | 0 | 1,606,731 | 1,606,731 | 1.5% |
| HealthCor Offshore GP | 0 | 1,606,731 | 0 | 1,606,731 | 1,606,731 | 1.5% |
| HealthCor Group | 0 | 4,004,600 | 0 | 4,004,600 | 4,004,600 | 3.7% |
| Arthur Cohen | 0 | 5,500,000 | 0 | 5,500,000 | 5,500,000 | 5.1% |
| Joseph Healey | 0 | 5,500,000 | 0 | 5,500,000 | 5,500,000 | 5.1% |
| HealthCor Sanatate Offshore Master Fund | 0 | 947,869 | 0 | 947,869 | 947,869 | 0.9% |
| HealthCor Offshore II GP | 0 | 947,869 | 0 | 947,869 | 947,869 | 0.9% |
| HealthCor Co-Invest Sanatate Master Fund | 0 | 1,450,000 | 0 | 1,450,000 | 1,450,000 | 1.3% |
| HealthCor Offshore III GP | 0 | 1,450,000 | 0 | 1,450,000 | 1,450,000 | 1.3% |
Follow Arthur B Cohen And Joseph Healey's Healthcor Management LP
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 1 of 17 – SEC Filing
SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED
PURSUANT TO RULE 13d-2
(Amendment No. )*
Bioverativ, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
09075E100
(CUSIP Number)
April 4,
2017
(Date of Event Which Requires Filing of this
Statement)
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
¨
Rule 13d-1(b)
x
Rule 13d-1(c)
¨
Rule 13d-1(d)
(Page 1 of 17 Pages)
*The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of
this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 2 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 2 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Management, L.P. | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Delaware | ||
| NUMBER OF SHARES BENEFICIALLY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 5,500,000 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 5,500,000 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 5,500,000 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 5.1% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| PN | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 3 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 3 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Associates, LLC | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Delaware | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 5,500,000 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 5,500,000 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 5,500,000 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 5.1% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| OO – Limited Liability company | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 4 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 4 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Offshore Master Fund, L.P. | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Cayman Islands | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 1,606,731 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 1,606,731 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 1,606,731 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 1.5% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| PN | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 5 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 5 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Offshore GP, LLC | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Delaware | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 1,606,731 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 1,606,731 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 1,606,731 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 1.5% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| OO – Limited Liability company | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 6 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 6 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Group, LLC | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Delaware | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 4,004,600 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 4,004,600 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 4,004,600 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 3.7% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| OO – Limited Liability company | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 7 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 7 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| Arthur Cohen | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| United States | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 5,500,000 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 5,500,000 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 5,500,000 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 5.1% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| IN | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 8 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 8 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| Joseph Healey | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| United States | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 5,500,000 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 5,500,000 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 5,500,000 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 5.1% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| IN | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 9 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 9 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Sanatate Offshore Master Fund, L.P. | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Cayman Islands | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 947,869 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 947,869 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 947,869 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 0.9% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| PN | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 10 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 10 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Offshore II GP, LLC | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Delaware | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 947,869 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 947,869 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 947,869 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 0.9% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| OO – Limited Liability company | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 11 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 11 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Co-Invest Sanatate Master Fund, L.P. | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Cayman Islands | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 1,450,000 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 1,450,000 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 1,450,000 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 1.3% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| PN | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 12 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 12 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS | |
| HealthCor Offshore III GP, LLC | ||
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) | |
| (a) x | ||
| (b) ¨ | ||
| (3) | SEC USE ONLY | |
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION | |
| Delaware | ||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | (5) SOLE VOTING POWER | |
| 0 | ||
| (6) SHARED VOTING POWER | ||
| 1,450,000 | ||
| (7) SOLE DISPOSITIVE POWER | ||
| 0 | ||
| (8) SHARED DISPOSITIVE POWER | ||
| 1,450,000 | ||
| (9) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | |
| 1,450,000 | ||
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES(see instructions) | ¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | |
| 1.3% | ||
| (12) | TYPE OF REPORTING PERSON (see instructions) | |
| OO – Limited Liability company | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 13 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 13 of 17 Pages |
| Item 1(a). | Name of Issuer: |
| Bioverativ, Inc. | |
| Item 1(b). | Address of Issuer’s Principal Executive Offices: |
| 225 Second Avenue, Waltham, MA 02451 | |
| Item 2(a, b, c). | Name of Person Filing: |
| (i) HealthCor Management, L.P., a Delaware limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (ii) HealthCor Associates, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (iii) HealthCor Offshore Master Fund, L.P., a Cayman Islands limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (iv) HealthCor Offshore GP, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (v) HealthCor Group, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (vi) Joseph Healey, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (vii) Arthur Cohen, 12 South Main Street, #203 Norwalk, CT 06854; | |
| (viii) HealthCor Sanatate Offshore Master Fund, L.P., a Cayman Islands limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (ix) HealthCor Offshore II GP, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; | |
| (x) HealthCor Co-Invest Sanatate Master Fund, L.P., a Cayman Islands limited partnership, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019; and | |
| (xi) HealthCor Offshore III GP, LLC, a Delaware limited liability company, Carnegie Hall Tower, 152 West 57th Street, 43rd Floor, New York, New York 10019. | |
| Both Mr. Healey and Mr. Cohen are United States citizens. | |
| The persons at (i) through (xi) above are collectively referred to herein as the “Reporting Persons”. |
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 14 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 14 of 17 Pages |
| Item 2(d). | Title of Class of Securities: Common Stock (the “Common Stock”) |
| Item 2(e). | CUSIP Number: 097075E100 |
| Item 3. | Not applicable. |
| Item 4. | Ownership. |
| The information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. | |
| Collectively, HealthCor Offshore Master Fund, L.P., HealthCor Sanatate Offshore Master Fund, L.P. and HealthCor Co-Invest Sanatate Master Fund, L.P. (each a “Fund” and together, the “Funds”) are the beneficial owners of a total of 4,004,600 shares of the Common Stock of the Issuer. In addition, HealthCor Management, L.P. manages separately managed accounts that collectively hold a total of 1,495,400 shares of the Common Stock of the Issuer. | |
| HealthCor Offshore GP, LLC is the general partner of HealthCor Offshore Master Fund, L.P. Accordingly, HealthCor Offshore GP, LLC may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Offshore Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor Offshore GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Offshore Master Fund, L.P. | |
| HealthCor Offshore II GP, LLC is the general partner of HealthCor Sanatate Offshore Master Fund, L.P. Accordingly, HealthCor Offshore II GP, LLC may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor Offshore II GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P. | |
| HealthCor Offshore III GP, LLC is the general partner of HealthCor Co-Invest Sanatate Master Fund, L.P. Accordingly, HealthCor Offshore III GP, LLC may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Co-Invest Sanatate Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor Offshore III GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Co-Invest Sanatate Master Fund, L.P. |
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 15 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 15 of 17 Pages |
| By virtue of its position as the investment manager of the Funds, HealthCor Management, L.P. may be deemed a beneficial owner of all the shares of Common Stock owned by the Funds, as well as those it manages through separately managed accounts. HealthCor Associates, LLC is the general partner of HealthCor Management, L.P. and thus may also be deemed to beneficially own the shares of Common Stock that are beneficially owned by the Funds. | |
| As the Managers of HealthCor Associates, LLC, Arthur Cohen and Joseph Healey exercise both voting and investment power with respect to the shares of Common Stock reported herein, and therefore each may be deemed a beneficial owner of such Common Stock. | |
| Each of the Reporting Persons hereby disclaims any beneficial ownership of any such shares of Common Stock in excess of their actual pecuniary interest therein. | |
| Item 5. | Ownership of Five Percent or Less of a Class: |
| If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨. | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
| Not Applicable | |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. |
| Not Applicable | |
| Item 8. | Identification and Classification of Members of the Group. |
| See Exhibit I. | |
| Item 9. | Notice of Dissolution of Group. |
| Not Applicable | |
| Item 10. | Certification. |
| By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. | |
| Exhibits: | |
| Exhibit I: | Joint Acquisition Statement |
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 16 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 16 of 17 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and correct.
DATED: April 13, 2017
| HEALTHCOR MANAGEMENT, L.P. | |||
| By: HealthCor Associates, LLC, its general partner | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
HEALTHCOR OFFSHORE GP, LLC, for itself and as general partner
of behalf of HEALTHCOR OFFSHORE MASTER FUND, L.P.
| By: HealthCor Group, LLC, its general partner | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 17 of 17 – SEC Filing
| CUSIP No. 097075E100 | 13G | Page 17 of 17 Pages |
HEALTHCOR OFFSHORE II GP, LLC, for itself and as general
partner of behalf of HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P.
| By: HealthCor Group, LLC, its general partner | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
HEALTHCOR OFFSHORE III GP, LLC, for itself and as general
partner of behalf of HEALTHCOR CO-INVEST SANATATE MASTER FUND, L.P.
| By: HealthCor Group, LLC, its general partner | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
HEALTHCOR ASSOCIATES, LLC
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
HEALTHCOR GROUP, LLC
| By: | /s/ Anabelle P. Gray | ||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel |
JOSEPH HEALEY, Individually
| /s/ Joseph Healey | ||
ARTHUR COHEN, Individually
| /s/ Arthur Cohen |
Follow Bioverativ Inc.
Follow Bioverativ Inc.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
